DFCM
ARCT icon

Dark Forest Capital Management’s Arcturus Therapeutics ARCT Stock Holding History

Dark Forest Capital Management’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-23,351
Closed -$247K – 1173
2025
Q1 		$247K Buy
+23,351
New +$371K 0.01% 1110
2023
Q4 		– Sell
-25,228
Closed -$645K – 490
2023
Q3 		$645K Sell
25,228
-8,676
-26% -$267K 0.05% 606
2023
Q2 		$972K Buy
33,904
+26,476
+356% +$721K 0.09% 310
2023
Q1 		$178K Buy
7,428
+6,808
+1,098% +$122K 0.04% 440
2022
Q4 		$10.5K Buy
+620
New +$10.8K ﹤0.01% 731
2022
Q1 		– Sell
-1
Closed – – 1263
2021
Q4 		$0 Sell
1
-298
-100% -$12.1K ﹤0.01% 1416
2021
Q3 		$14K Buy
+299
New +$13.4K 0.01% 909

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Dark Forest Capital Management's ARCT Position: Q2 2025 in Review

Dark Forest Capital Management sold out of Arcturus Therapeutics (ARCT) in Q2 2025, closing a stake of 23,351 shares — an estimated $247K sold.

Dark Forest Capital Management first reported a position in ARCT in Q3 2021 and held it in 7 quarters. The position peaked at $972K in Q2 2023. 143 funds tracked by Wall St. Rank hold ARCT as of Q2 2025.

  • Dark Forest Capital Management reported no remaining Arcturus Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Dark Forest Capital Management sold 23,351 Arcturus Therapeutics shares in Q2 2025, an estimated $247K.
  • Dark Forest Capital Management first reported a position in Arcturus Therapeutics in Q3 2021 and held it in 7 quarters.
  • Dark Forest Capital Management's Arcturus Therapeutics position peaked at $972K in Q2 2023.
  • 143 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2025.

Based on Dark Forest Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.